QIAGEN has announced the approval of its NeuMoDx human immunodeficiency virus type 1 (HIV-1) assay for use in Thailand. This approval completes the suite of blood-borne virus (BBV) testing available in the country, alongside the previously approved hepatitis B virus (HBV) and hepatitis C virus (HCV) quantitative assays.

Every day, millions of patients infected with blood-borne viruses require routine testing to quantify their viral load, aiding in the assessment of antiviral therapy needs. QIAGEN's NeuMoDx molecular platform offers fully automated assays for HIV-1, HBV, and HCV, utilizing real-time polymerase chain reaction (RT-PCR) technology to deliver reliable and accurate results.

The NeuMoDx HIV-1 Quant Assay is specifically designed for the quantitation and detection of HIV-1 RNA in human plasma. It serves as a valuable tool in the clinical management of HIV-1 infected patients, monitoring the effects of antiretroviral treatment and aiding in the diagnosis of HIV-1 infection.

With a simple and intuitive 3-step workflow, the NeuMoDx system offers fast turnaround times and true random access testing capabilities. Room temperature stable test strips and universal reagents ensure convenience and efficiency, while the system's versatility allows for the testing of up to 30 different assays, including in-vitro diagnostics (IVD) certified assays, self-developed tests (SDTs), and research use only (RUO) assays.

"The approval of NeuMoDx HIV-1 quantitative assay now allows testing for the full complement of BBV assays available on NeuMoDx, providing a significant benefit for patients with accurate and timely results. The test will play a vital role in controlling the spread of these diseases, addressing major needs for clinical testing in infectious diseases," said Pimlada Sirichadkulburdee, National Sales Manager, Thailand, at QIAGEN.

In addition to blood-borne viruses, the NeuMoDx system offers assays for transplant-associated viruses, sexual and reproductive health, as well as respiratory diseases, further expanding its utility in clinical settings.